Articles (peer-reviewed)
Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development, Barbara Friedland, Holly Gundacker, Sharon Achilles, Beatrice A. Chen, Craig Hoesley, Barbra A. Richardson, Clifton W. Kelly, Jeanna Piper, Sherri Johnson, Brid Devlin, John Steytler, Kyle Kleinbeck, Bindi Dangi, Chantel Friend, Mei Song, Barbara Mensch, Ariane van der Straten, Cindy Jacobson, Craig W. Hendrix, Jill Brown, Diana Blithe, Sharon L. Hiller, and on behalf of the MTN-030/IPM 041 and MTN-044/IPM 053/CCN019 Protocol Teams for the Microbicide Trials Network and the Contraceptive Clinical Trials Network
Acceptability of the dapivirine vaginal ring and daily oral pre-exposure prophylaxis (PrEP) during pregnancy in Malawi, South Africa, Uganda, and Zimbabwe, Alinda M. Young, Marie Stoner, Florence Mathebula, Rebone Mohuba, Alejandro Baez, Linly Seyama, Prisca Mutero, Juliane Etima, Zayithwa Fabiano, Lee Fairlie, Ashley Mayo, Jennifer E. Balkus, Mei Song, Katherine Bunge, Jeanna Piper, Ivan C. Balan, Ariane van der Straten, and Elizabeth T. Montgomery
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: A randomised, open-label, crossover trial, Gonasagrie Nair, Connie Celum, Daniel Szydlo, Elizabeth R. Brown, Carolyne Akello, Rita Nakalega, et al., and John Steytler
Assessing per-sex-act HIV-1 risk reduction among women using the Dapivirine Vaginal Ring, Randy Stalter, Tracy Q. Dong, Craig W. Hendrix, Thesla Palanee-Phillips, Ariane van der Straten, Sharon L. Hillier, Flavia Matovu Kiweewa, Nyaradzo M. Mgodi, Mark A. Marzinke, Linda-Gail Bekker, Lydia Soto-Torres, Jared M. Baeten, Elizabeth R. Brown, and MTN-020-ASPIRE Study Team
Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study), Kenneth Ngure, Barbara Friedland, Daniel W. Szydlo, Sarah Roberts, Morgan Garcia, Lisa Levy, Carolyne Akello, Krishnaveni Reddy, Thesla Palanee-Phillips, Pippa Macdonald, Bekezela Siziba, Lydia Soto-Torres, Sybil Hosek, Sharon L. Hillier, Gonasagrie Nair, Connie Celum, and Ariane van der Straten
Higher acceptability of the monthly dapivirine ring versus daily oral pre-exposure prophylaxis among adolescent girls and young women in sub-Saharan Africa in the REACH trial, Barbara Friedland, Erica N. Browne, Sarah T. Roberts, Kenneth Ngure, Rita Nakalega, Pippa Macdonald, Cynthia Nombeko Mpongo, Siyanda Tenza, Nomsa Mhlanga, Daniel Szydlo, Sherri Johnson, Tara McClure, Gonasagrie Nair, Connie Celum, Sharon L. Hillier, Ariane van der Straten, and MTN-034 REACH clinical trial team
Transport and permeation properties of dapivirine: Understanding potential drug-drug interactions, Ruohui Zheng, Guru R. Valicherla, Junmei Zhang, Jeremy Nuttall, Peter Silvera, Leslie J. Marshall, Philip E. Empey, and Lisa C. Rohan
Audio/Video
Coming Full Circle: Microbicide Development at the Population Council, James Sailer, Barbara Friedland, Diantha Pillay, Christopher J. Elias, Sharon L. Hillier, and Georgina Caswell
PrEP Ring for HIV Prevention—Video series, Population Council
Briefs
Transition to Scale: PrEP Ring Project—Botswana results dissemination brief, IPM South Africa
Transition to Scale: PrEP Ring Project—Rwanda results dissemination brief, IPM South Africa
Fact Sheets
3-Month Dapivirine Vaginal Ring: A longer-acting dapivirine vaginal ring for HIV protection, IPM South Africa
Dapivirine Levonorgestrel Vaginal Ring: A multipurpose prevention ring for HIV and contraceptive protection, IPM South Africa
Dapivirine Vaginal Ring: A long-acting ring for women's HIV prevention, IPM South Africa
IPM South Africa, NPC: Pioneering HIV prevention options for women, IPM South Africa
Support for healthcare provider education—Overview, IPM South Africa
Guides/Toolkits
Global Healthcare Provider Training Package: Dapivirine Vaginal Ring (PrEP Ring), IPM South Africa
Newsletters
The PrEP Ring Quarterly—Edition 1, October 2024, IPM South Africa
The PrEP Ring Quarterly—Edition 2, March 2025, IPM South Africa
The PrEP Ring Quarterly—Edition 3, July 2025, IPM South Africa
The PrEP Ring Quarterly—Edition 4, October 2025, IPM South Africa
Presentations
Acceptability and feasibility study for the DVR in three cities in Indonesia (Bali, Makassar and Tegal), ThinkPlace and UNAIDS
Reports
Acceptability and feasibility study for the Dapivirine Vaginal Ring in Cambodia: A qualitative study on the Dapivirine Vaginal Ring for use amongst cisgender women at substantial HIV risk in Cambodia, Kingdom of Cambodia, National Center for HIV/AIDS, Dermatology and STD